HIV 1 Infection Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
Not yet recruiting
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +3 more
2021-11-22
Nov 22, 2021
E
Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART
Not yet recruiting
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +3 more
2021-11-22
Nov 22, 2021
U
Supporting Treatment Adherence for Resilience and Thriving (START)
Not yet recruiting
  • Adherence, Medication
  • +2 more
  • START mHealth Intervention
  • Miami, Florida
    University of MIami
2021-11-15
Nov 15, 2021
A
Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine
Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam University Medical Centers, location AMC
2021-11-29
Nov 29, 2021
U
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
Not yet recruiting
  • Depression
  • +2 more
  • Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)
  • Antiretroviral Therapy (ART) Adherence Counseling
  • Miami, Florida
    University of Miami
2021-11-15
Nov 15, 2021
R
2000HIV Trained Innate Immunity in HIV Elite Controllers
Active, not recruiting
  • HIV-1-infection
    • Amsterdam, Netherlands
    • +2 more
    2021-11-16
    Nov 16, 2021
    U
    Poor Sleep and Inflammation in HIV-Infected Adults
    Enrolling by invitation
    • HIV-1-infection
    • +2 more
    • Sleep deprivation
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    2021-11-19
    Nov 19, 2021
    D
    Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
    Not yet recruiting
    • Hypertension
    • +3 more
      • (no location specified)
      2021-11-10
      Nov 10, 2021
      U
      Implementing Cabenuva in Arkansas HIV Programs
      Not yet recruiting
      • HIV-1-infection
      • +2 more
      • Home visit delivery strategy
      • Little Rock, Arkansas
        University of Arkansas for Medical Sciences
      2021-11-09
      Nov 9, 2021
      S
      Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
      Not yet recruiting
      • HIV-1-infection
      • B/F/TAF
      • TDF-based triple ART regimen switching to B/F/TAF
      • Shanghai, Shanghai, China
      • +2 more
      2021-11-03
      Nov 3, 2021
      A
      Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
      Recruiting
      • HIV-1-infection
        • Port-au-Prince, Bicentaire, Haiti
        • +13 more
        2021-11-04
        Nov 4, 2021
        U
        A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women - 2020
        Completed
        Has Results
        • Perinatal Depression
        • HIV-1-infection
        • Lusaka, Zambia
        • +1 more
        2021-10-12
        Oct 12, 2021
        N
        Pharmacokinetics of SAR441236
        Recruiting
        • HIV-1-infection
        • SAR441236
        • +2 more
        • Birmingham, Alabama
        • +26 more
        2021-11-04
        Nov 4, 2021
        U
        Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV - 2020
        Completed
        • Hepatic Steatosis
        • HIV-1-infection
        • London, United Kingdom
        • +5 more
        2021-11-03
        Nov 3, 2021
        U
        Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
        Recruiting
        • HIV-1-infection
        • Salt Lake City, Utah
        • +7 more
        2021-11-03
        Nov 3, 2021
        U
        2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
        Active, not recruiting
        • HIV-1-infection
        • Dual versus triple therapy in treatment of HIV-1 infection.
        • Ghent, Belgium
          Ghent University Hospital
        2021-10-26
        Oct 26, 2021
        H
        Prospective Observational Cohort HIV & STI Study in Europe
        Active, not recruiting
        • HIV Infections
        • +3 more
        • Determine the Incidence and Point Prevalence
        • Bordeaux, France
        • +14 more
        2021-10-27
        Oct 27, 2021
        G
        Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV
        Active, not recruiting
        • HIV-1-infection
        • Oral Lenacapavir
        • +5 more
        • Phoenix, Arizona
        • +52 more
        2021-10-27
        Oct 27, 2021
        G
        Pharmacokinetic, Safety, and Efficacy of B/F/TAF in HIV-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters
        Recruiting
        • HIV-1-infection
        • Long Beach, California
        • +12 more
        2021-10-25
        Oct 25, 2021
        U
        Uganda PrEP and Harm Reduction Evaluation
        Not yet recruiting
        • HIV-1-infection
        • Integrating PrEP delivery
        • Kampala, Uganda
          Infectious Diseases Institute, Makerere University
        2021-10-22
        Oct 22, 2021
        A
        Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).
        Recruiting
        • Covid19
        • +2 more
        • Immune response study
        • Madrid, Spain
          Hospital Ramon y Cajal
        2021-10-23
        Oct 23, 2021
        M
        MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy - 2021
        Completed
        • HIV-1-infection
        • MGD014
        • Chapel Hill, North Carolina
          University of North Carolina Chapel Hill
        2021-10-19
        Oct 19, 2021
        G
        Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
        Active, not recruiting
        Has Results
        • HIV-1-infection
        • Oral Lenacapavir
        • +4 more
        • Los Angeles, California
        • +74 more
        2021-09-28
        Sep 28, 2021
        U
        The Partners Scale-Up Project - 2021
        Completed
        • HIV-1-infection
        • Integrated PrEP as a bridge to ART HIV-1 prevention strategy
        • +2 more
        • Kisumu, Kenya
        • +1 more
        2021-10-17
        Oct 17, 2021
        U
        Kenya HIV Self-Testing in PrEP Delivery
        Active, not recruiting
        • HIV-1-infection
        • 6-month PrEP + blood-based HIV self-test
        • 6-month PrEP + oral fluid HIV self-test
        • Thika, Kenya
          Partners in Health Research and Development - Thika House
        2021-10-17
        Oct 17, 2021